• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病痴呆和路易体痴呆发病机制的当前概念与争议

Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.

作者信息

Weil Rimona S, Lashley Tammaryn L, Bras Jose, Schrag Anette E, Schott Jonathan M

机构信息

Dementia Research Centre, UCL Institute of Neurology, London, UK.

Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.

出版信息

F1000Res. 2017 Aug 30;6:1604. doi: 10.12688/f1000research.11725.1. eCollection 2017.

DOI:10.12688/f1000research.11725.1
PMID:28928962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5580419/
Abstract

Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB) are relentlessly progressive neurodegenerative disorders that are likely to represent two ends of a disease spectrum. It is well established that both are characterised pathologically by widespread cortical Lewy body deposition. However, until recently, the pathophysiological mechanisms leading to neuronal damage were not known. It was also not understood why some cells are particularly vulnerable in PDD/DLB, nor why some individuals show more aggressive and rapid dementia than others. Recent studies using animal and cell models as well as human post-mortem analyses have provided important insights into these questions. Here, we review recent developments in the pathophysiology in PDD/DLB. Specifically, we examine the role of pathological proteins other than α-synuclein, consider particular morphological and physiological features that confer vulnerabilities on some neurons rather than others, and finally examine genetic factors that may explain some of the heterogeneity between individuals with PDD/DLB.

摘要

帕金森病痴呆(PDD)和路易体痴呆(DLB)是无情进展的神经退行性疾病,它们可能代表了疾病谱的两端。众所周知,两者在病理上均以广泛的皮质路易体沉积为特征。然而,直到最近,导致神经元损伤的病理生理机制仍不明确。人们也不明白为什么有些细胞在PDD/DLB中特别脆弱,也不明白为什么有些人比其他人表现出更具侵袭性和快速进展的痴呆。最近使用动物和细胞模型以及人体尸检分析的研究为这些问题提供了重要的见解。在这里,我们回顾PDD/DLB病理生理学的最新进展。具体而言,我们研究了除α-突触核蛋白之外的病理性蛋白质的作用,考虑了使某些神经元而非其他神经元具有易损性的特定形态和生理特征,最后研究了可能解释PDD/DLB患者个体间某些异质性的遗传因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b073/5580419/dd91e1385a13/f1000research-6-12667-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b073/5580419/dd91e1385a13/f1000research-6-12667-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b073/5580419/dd91e1385a13/f1000research-6-12667-g0000.jpg

相似文献

1
Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.帕金森病痴呆和路易体痴呆发病机制的当前概念与争议
F1000Res. 2017 Aug 30;6:1604. doi: 10.12688/f1000research.11725.1. eCollection 2017.
2
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.路易体痴呆与帕金森病痴呆:当前的概念和争议。
J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8.
3
Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?路易体痴呆和帕金森病痴呆是同一种疾病吗?
BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8.
4
Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.帕金森病痴呆死后脑组织中病理标志物的表达增加,与路易体痴呆相比。
BMC Neurosci. 2022 Jan 4;23(1):3. doi: 10.1186/s12868-021-00687-4.
5
[Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].帕金森病痴呆与路易体痴呆的病理及临床比较
Orv Hetil. 2020 May 1;161(18):727-737. doi: 10.1556/650.2020.31715.
6
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
7
Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?帕金森病痴呆与路易体痴呆之间存在形态学差异吗?
Parkinsonism Relat Disord. 2022 Jul;100:24-32. doi: 10.1016/j.parkreldis.2022.05.024. Epub 2022 Jun 3.
8
Locus Coeruleus Pathology Indicates a Continuum of Lewy Body Dementia.蓝斑病理提示路易体痴呆的连续谱。
J Parkinsons Dis. 2021;11(4):1641-1650. doi: 10.3233/JPD-212748.
9
Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.路易体病和阿尔茨海默病的脑淀粉样血管病的患病率、分布和严重程度不同。
Acta Neuropathol Commun. 2024 Feb 15;12(1):28. doi: 10.1186/s40478-023-01714-7.
10
Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson's disease dementia.神经丝轻链在海马旁回皮质中增加,并与帕金森病痴呆的病理标志相关。
Transl Neurodegener. 2023 Jan 20;12(1):3. doi: 10.1186/s40035-022-00328-8.

引用本文的文献

1
The Mitochondrial Foundations of Parkinson's Disease: Therapeutic Implications.帕金森病的线粒体基础:治疗意义
Aging Dis. 2025 Apr 28;16(5):2695-2720. doi: 10.14336/AD.2025.0440.
2
Effect of Deep Brain Stimulation on Parkinson Disease Dementia: A Systematic Review and Meta-analysis.深部脑刺激对帕金森病痴呆的影响:一项系统评价和荟萃分析。
Basic Clin Neurosci. 2024 Mar-Apr;15(2):157-164. doi: 10.32598/bcn.2021.3420.1. Epub 2024 Mar 1.
3
Investigation of the genetic aetiology of Lewy body diseases with and without dementia.

本文引用的文献

1
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.路易体痴呆的诊断与管理:DLB联盟第四次共识报告
Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7.
2
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.通过大规模全外显子组测序发现帕金森病候选基因并进行功能优先级排序。
Genome Biol. 2017 Jan 30;18(1):22. doi: 10.1186/s13059-017-1147-9.
3
Selective neuronal vulnerability in Parkinson disease.
伴有和不伴有痴呆的路易体病的遗传病因学研究。
Brain Commun. 2024 May 31;6(4):fcae190. doi: 10.1093/braincomms/fcae190. eCollection 2024.
4
Investigation of the genetic aetiology of Lewy body diseases with and without dementia.伴或不伴痴呆的路易体病的遗传病因学研究。
medRxiv. 2023 Oct 27:2023.10.17.23297157. doi: 10.1101/2023.10.17.23297157.
5
Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder.孤立性快速眼动睡眠行为障碍患者脑胆碱能功能障碍的进展。
Eur J Neurol. 2024 Jan;31(1):e16101. doi: 10.1111/ene.16101. Epub 2023 Oct 17.
6
Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia.形态学特征可将路易体痴呆与伴有和不伴有痴呆的帕金森病区分开来。
J Neural Transm (Vienna). 2023 Jul;130(7):891-904. doi: 10.1007/s00702-023-02660-3. Epub 2023 Jun 12.
7
Role of piRNA biogenesis and its neuronal function in the development of neurodegenerative diseases.piRNA生物合成及其神经元功能在神经退行性疾病发展中的作用。
Front Aging Neurosci. 2023 May 3;15:1157818. doi: 10.3389/fnagi.2023.1157818. eCollection 2023.
8
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.α-突触核蛋白构象揭示了与 α-突触核蛋白病临床异质性的联系。
Transl Neurodegener. 2023 Mar 14;12(1):12. doi: 10.1186/s40035-023-00342-4.
9
The Complex Mechanisms by Which Neurons Die Following DNA Damage in Neurodegenerative Diseases.神经退行性疾病中 DNA 损伤后神经元死亡的复杂机制。
Int J Mol Sci. 2022 Feb 24;23(5):2484. doi: 10.3390/ijms23052484.
10
High-Throughput Sequencing Haplotype Analysis Indicates in Gene a Potential Risk Factor for Endemic Parkinsonism in Southeastern Moravia, Czech Republic.高通量测序单倍型分析表明,在捷克共和国摩拉维亚东南部,基因是地方性帕金森病的一个潜在风险因素。
Life (Basel). 2022 Jan 14;12(1):121. doi: 10.3390/life12010121.
帕金森病中的选择性神经元易损性。
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113. doi: 10.1038/nrn.2016.178.
4
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.突触核蛋白病生存及痴呆症发病的神经病理学和遗传学关联:一项回顾性分析
Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.
5
Effects of α-synuclein on axonal transport.α-突触核蛋白对轴突运输的影响。
Neurobiol Dis. 2017 Sep;105:321-327. doi: 10.1016/j.nbd.2016.12.008. Epub 2016 Dec 9.
6
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.临床变量和生物标志物在新诊断帕金森病患者认知障碍预测中的作用:一项队列研究
Lancet Neurol. 2017 Jan;16(1):66-75. doi: 10.1016/S1474-4422(16)30328-3. Epub 2016 Nov 18.
7
Abolishing the 1-year rule: How much evidence will be enough?废除一年规则:多少证据才足够?
Mov Disord. 2016 Nov;31(11):1623-1627. doi: 10.1002/mds.26796. Epub 2016 Sep 26.
8
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.路易体疾病谱系中的脑脊液阿尔茨海默病生物标志物:一项大型多中心队列研究结果
J Alzheimers Dis. 2016 Aug 18;54(1):287-95. doi: 10.3233/JAD-160322.
9
Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies.帕金森病和路易体痴呆中β-淀粉样蛋白病理学的分布与负荷
J Neuropathol Exp Neurol. 2016 Oct;75(10):936-945. doi: 10.1093/jnen/nlw070. Epub 2016 Aug 11.
10
The amyloid hypothesis of Alzheimer's disease at 25 years.阿尔茨海默病淀粉样蛋白假说25年回顾
EMBO Mol Med. 2016 Jun 1;8(6):595-608. doi: 10.15252/emmm.201606210. Print 2016 Jun.